Clinical Trial Update: Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial results comparing nepafenac 0.1% eye drops to ketorolac trometamol 0.5% eye drops and placebo in cataract patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts

Drugs mentioned

• Ketorolac trometamol 0.5% Eye Drops (ketorolac trometamol)
• Nepafenac 0.1% Eye Drops (nepafenac)

Snippet

Sponsor: Alcon Research | Conditions: Cataracts | Phase 3 | Status: COMPLETED